Methylene Blue Drug Interactions: What You Need to Know

Methylene blue is a powerful compound with a long medical history — but like any active substance, it interacts with certain medications and supplements in ways that range from mildly inconvenient to potentially dangerous. Understanding these interactions is essential before adding methylene blue to your routine.

This article is for informational purposes only. Always consult a qualified healthcare provider before starting methylene blue supplementation, especially if you are taking prescription medications.

The Most Important Interaction: Serotonergic Drugs

The most clinically significant interaction involves serotonergic medications — drugs that increase serotonin activity in the nervous system. Methylene blue inhibits monoamine oxidase A (MAO-A), an enzyme responsible for breaking down serotonin. When combined with medications that also raise serotonin levels, this can trigger serotonin syndrome — a potentially life-threatening condition characterized by agitation, rapid heart rate, high blood pressure, fever, and in severe cases, seizures.

Medications to avoid combining with methylene blue include:

  • SSRIs (e.g., fluoxetine, sertraline, escitalopram, paroxetine)
  • SNRIs (e.g., venlafaxine, duloxetine)
  • MAOIs (e.g., phenelzine, tranylcypromine)
  • Tricyclic antidepressants (e.g., amitriptyline, clomipramine)
  • Tramadol — an opioid pain reliever with serotonergic activity
  • Linezolid — an antibiotic that also inhibits MAO
  • St. John's Wort — an herbal supplement that raises serotonin
  • 5-HTP and tryptophan — serotonin precursors

This interaction is dose-dependent. At the very low doses used in supplements (0.5–4 mg), the risk is substantially lower than at clinical doses (1–2 mg/kg IV used in surgery). However, the FDA has issued warnings about methylene blue even at low doses when combined with serotonergic drugs. If you take any of the above, do not use methylene blue without physician guidance.

G6PD Deficiency

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic condition that affects red blood cells. Methylene blue requires G6PD to exert its antioxidant effects — without it, methylene blue can paradoxically cause oxidative damage to red blood cells, leading to hemolytic anemia. G6PD deficiency is more common in people of African, Mediterranean, and Middle Eastern descent.

If you have a known or suspected G6PD deficiency, methylene blue is contraindicated. Testing is available through a standard blood panel.

Medications That May Interact

Beyond serotonergic drugs, other potential interactions include:

  • Blood thinners (warfarin, etc.) — Methylene blue may affect cytochrome P450 enzymes involved in drug metabolism, potentially altering warfarin levels. Monitor INR closely if using both.
  • Antihypertensives — Methylene blue can increase blood pressure at higher doses. Those on blood pressure medication should monitor accordingly.
  • Chemotherapy agents — Some research suggests methylene blue may interact with certain cancer medications; discuss with an oncologist before use.
  • Nitrates and erectile dysfunction medications — Both methylene blue and nitrates affect nitric oxide pathways; combining them may cause unpredictable blood pressure effects.

Supplements to Be Cautious With

  • High-dose melatonin — Both influence serotonin/melatonin pathways; use with awareness.
  • SAMe (S-adenosylmethionine) — Has serotonergic properties; caution advised.
  • High-dose niacin (B3) — Can affect MAO pathways at very high doses.

What Is Generally Safe to Combine

At supplemental doses, methylene blue is commonly and generally safely combined with:

  • Red light / photobiomodulation therapy
  • CoQ10 and other mitochondrial support supplements
  • NAD+ precursors (NMN, NR)
  • Magnesium
  • Omega-3 fatty acids
  • Most standard vitamins and minerals

The Bottom Line

Methylene blue is safe for most healthy adults at supplemental doses, but the serotonin interaction and G6PD contraindication are serious enough to warrant careful screening. If you are healthy, not on serotonergic medications, and have no G6PD deficiency, low-dose methylene blue from a pharmaceutical-grade source carries a very manageable risk profile.

Always disclose new supplements to your healthcare provider, particularly if you take prescription medications.

Start With Quality

Reviv Health's methylene blue drops are pharmaceutical grade, precisely concentrated, and designed for supplemental use. Quality and purity are the baseline — from there, your healthcare provider can help you determine what works safely for your situation.

Shop at revivhealth.com.


References

  1. Methylene blue serotonin toxicity and MAO inhibition - "MB is a potent reversible inhibitor of MAO A"
  2. Methylene blue serotonin toxicity and MAO inhibition - "The use of MB by infusion in combination with other 5-hydroxytryptaminergic agents could lead to the ST syndrome"
  3. StatPearls: Methylene Blue pharmacology overview - "Methylene blue is contraindicated in patients with G6PD deficiency."
  4. StatPearls: Methylene Blue pharmacology overview - "Methylene blue is generally well-tolerated but carries several critical adverse effects and contraindications."
  5. Methylene blue neuroprotection and mitochondrial function - "The excellent safety record of MB is well established by a century of medical use."
NP

Written by Natalie Parker

Natalie Parker is a health and wellness researcher specializing in mitochondrial science and emerging supplements. She writes for Reviv Health, covering the latest research on Methylene Blue and cellular optimization.

Share information about your brand with your customers. Describe a product, make announcements, or welcome customers to your store.